Reports from longitudinal neuroimaging studies on an Alzheimer’s disease neuroimaging initiative (ADNI) cohort indicate that females with AD accumulate higher levels of pathological proteins (Aβ and tau), have 1–1.5% faster atrophy rates in the hippocampus than males, and have worse cognitive abilities [41,42]. The gene discussed is MAPT; the disease is Alzheimer disease.